MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).

A Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-0941 in Japanese Patients With Type 2 Diabetes

The multiple dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of MK-0941 in Japanese patients with Type 2 Diabetes.

Inclusion Criteria:

• Japanese Male or Female between 20 to 65 years of age
• Diagnosis of Type 2 Diabetes
• Patient being treated by diet and exercise alone

Exclusion Criteria:

• Patient has a history of Type 1 Diabetes
• Patient is being treated with glaucoma medications
• Patient has donated blood or participated in another clinical study in the past 12 weeks
• Patient is a regular user of any illicit drugs or has a history of drug, including alcohol, abuse